American Well Corp(AMWL) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -4.76 | Insider Own | 19.06% | Shs Outstand | 15.3M | Perf Week | 9.81% |
| Market Cap | 0.23B | Forward P/E | - | EPS next Y | 18.18% | Insider Trans | -2.35% | Shs Float | 13.8M | Perf Month | 0.82% |
| Enterprise Value | 0.05B | PEG | - | EPS next Q | -0.78 | Inst Own | 42.41% | Short Float | 1.25% | Perf Quarter | 22.09% |
| Income | -0.08B | P/S | 1.05 | EPS this Y | 56.96% | Inst Trans | 6.73% | Short Ratio | 1.63 | Perf Half Y | 120.52% |
| Sales | 0.22B | P/B | 1.04 | EPS next 5Y | 38.59% | ROA | -21.82% | Short Interest | 0.17M | Perf YTD | 175.76% |
| Book/sh | 13.07 | P/C | 1.17 | EPS past 3/5Y | 32.88% 20.73% | ROE | -31.01% | 52W High | -7% ($14.56) | Perf Year | 143.09% |
| Cash/sh | 11.57 | P/FCF | - | Sales past 3/5Y | -3.47% 0.33% | ROIC | -35.31% | 52W Low | 264.96% ($3.71) | Perf 3Y | -35.52% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 40.98% | Gross Margin | 37.05% | Volatility(W/M) | 6.44% 6.47% | Perf 5Y | -92.32% |
| Dividend TTM | - | EV/Sales | 0.23 | Sales Y/Y TTM | -19% | Oper. Margin | -33.15% | ATR (14) | 0.78 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.86 | EPS Q/Q | 52.21% | Profit Margin | -35.75% | RSI (14) | 56.12 | Recom | 2.75 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.87 | Sales Q/Q | -26.59% | SMA20 | 5.62% ($12.82) | Beta | 1.72 | Target Price | $12.33 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2026/11/3 | SMA50 | 5.92% ($12.78) | Rel Volume | 1.24 | Prev Close | $13.57 |
| Employees | 562 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 31.4% 4.35% | SMA200 | 54.8% ($8.75) | Avg Volume(3M) | 0.11M | Price | $13.54 |
| IPO | 2020/9/17 | Option/Short | Yes/Yes | Trades | 1249 | Volume | 130,862 | Change | -0.22% |
🩺 Amwell (Amwell) is a leading U.S. telehealth platform company. It provides digital care infrastructure to hospitals, insurers, and employers covering everything from acute to chronic disease management, and operates on a business model that combines subscription-based platform fees with per-visit consultation charges. The company has been expanding the telehealth ecosystem on the back of its extensive network of hospital partnerships and collaborations with insurance providers.
Over the past 1 year, on the higher side
7% below its 1-year high.
Traded about as much as usual. That is 124% of its average volume.
Next earnings report: November 3
7 days to go.
AMWL has a sound balance sheet but weak earning power
Of every $100 in sales, $33.15 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +57.0% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $105. Peers typically go for $70.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -92.3%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership looks stable
Institutions hold 42.4%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #24 of 41 in the industry
Based on market cap of $230M.
CTEV#23 Claritev Corp $365M PER - AMWL#24 American Well Corp $230M PER - 
SPOK#25 Spok Holdings Inc $214M PER 17.6 
SY#26 So-Young International Inc ADR $180M PER - 
OPRX#27 OptimizeRx Corp $171M PER 38.6 
FAQ
What kind of company is AMWL?
AMWL belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of AMWL?
The market cap of AMWL is approximately $230M, ranking 3,904 within its sector.
What is the 52-week high and low for AMWL?
AMWL has recorded a 52-week high of $14.56 and a low of $3.71.
